4.7 Review

The ubiquitin-proteasome system in spongiform degenerative disorders

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.bbadis.2008.08.006

Keywords

Transmissible spongiform encephalopathy (TSE); Oxidative stress; Autophagy; Endocytic trafficking

Funding

  1. National Institutes of Health [NS055468, NS047575, NS047199, ES015813, NS050650]
  2. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015813] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047575, F31NS055468, R01NS047199, R01NS050650] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Spongiform degeneration is characterized by vacuolation in nervous tissue accompanied by neuronal death and gliosis. Although spongiform degeneration is a hallmark of prion diseases, this pathology is also present in the brains of patients Suffering from Alzheimer's disease, diffuse Lewy body disease, human immunodeficiency virus (HIV) infection, and Canavan's spongiform leukodystrophy. The shared outcome of spongiform degeneration in these diverse diseases suggests that common cellular mechanisms must underlie the processes of spongiform change and neurodegeneration in the central nervous system. Immunohistochemical analysis of brain tissues reveals increased ubiquitin immunoreactivity in and around areas of spongiform change, suggesting the involvement of ubiquitin-proteasome system dysfunction ill the pathogenesis of spongiform neurodegeneration. The link between aberrant ubiquitination and spongiform neuroegeneration has been strengthened by the discovery that a null Mutation in the E3 ubiquitin-protein ligase mahogunin ring finger-1 (Mgrn 1) causes an autosomal recessively inherited form of spongiform neurodegeneration in animals. Recent studies have begun to suggest that abnormal ubiquitination may alter intracellular signaling and cell functions via proteasome-dependent and proteasome-independent mechanisms. leading to spongiform degeneration and neuronal cell death. Further elucidation of the pathogenic pathways involved in spongiform neurodegeneration should facilitate the development of novel rational therapies for treating prion diseases, HIV infection. and other spongiform degenerative disorders. (C) 2008 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available